Detailed price information for Invo Fertility Inc (IVF-Q) from The Globe and Mail including charting and trades.

Goren, INVO's CFO since July 2021, was appointed chief business officer, as well as chief executive officer of the fertility clinics subsidiary, INVO Centers LLC.

INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and ...

SARASOTA, Fla. and INDIANAPOLIS, Nov. 28, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, ...

Investors might want to bet on Invo BioScience Inc. (INVO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

SARASOTA, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced ...

Invo reports $1.38 million in quarterly sales, representing a 396.15% increase over sales of $278,140 from the same period last year. The company says it remains on-track with its goal of reaching ...

Valued at less than $54 million in market capitalization, and with total annual sales barely passing the $1 million mark, Sarasota, Florida-based INVO Bioscience (INVO) is hardly a household name -- ...

INVO Bioscience (NASDAQ:INVO) shares are trading higher on Monday after the company announced it signed binding agreements to acquire Wisconsin Fertility Institute. The purchase price of the ...

The future of transportation is about to leap off the ground, quite literally, thanks to Invo Station, a company poised to transform air travel with its silent, autonomous, and safe electric flying ...